After seeing results from GOG238, is there a subset of patients that might still benefit from chemoradiation for centrally recurrent endometrial cancer?
For example, do you think young patients might potentially benefit from the addition of cisplatin, knowing the average age in this study was 65.
Community PollStarted
Do you utilize sensitizing chemotherapy for patients undergoing pelvic RT for recurrent endometrial cancer?
22 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on
It’s hard to know who would benefit but use for bulky or high grade central recurrence. Bulky is subjective but usually for lesions that are more likely to need interstitial brachytherapy.
Join for free or sign in to see the full answer